2020 Speakers

(July 19, 2019)

Precision Health

Catherine Alix-Panabières, PhD, Director, Laboratory of Rare Human Circulating Cells (LCCRH), Pathology and Onco-Biology Department, University Medical Center of Montpellier

Leonela Amoasii, PhD, Director, Research Gene Editing, Exonics Therapeutics, Inc.

Scott V. Bratman, MD, PhD, Radiation Oncologist, Radiation Medicine Program; Scientist, Princess Margaret Cancer Centre, University Health Network; Assistant Professor, Depts of

Charles Chiu, MD, PhD, Professor, Laboratory Medicine and Medicine/Infectious Diseases, Director, UCSF-Abbott Viral Diagnostics and Discovery Center, Associate Director, UCSF Clinical Microbiology Laboratory, UCSF School of Medicine

Brian Dougherty, PhD, MBA, Executive Director, Translational Science, Oncology IMED, AstraZeneca

Bruno Gomes, PhD, Head of Biomarkers Oncology, Roche Pharma Research and Early Development, Roche Innovation Center Basel

Ralph Graeser, PhD, Transl. Medicine + Clin. Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG

Kenneth C. Hohmeier, PharmD, Director, Community Affairs, Associate Professor, Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center

Shana O. Kelley, PhD, Professor, Department of Biochemistry, Leslie Dan Faculty of Pharmacy, University of Toronto

Donald Klepser, PhD, MBA, Associate Professor and Vice Chair, Pharmacy Practice, University of Nebraska Medical Center

Michael S. Lawrence, PhD, Assistant Professor of Pathology, Harvard Medical School; Assistant Geneticist, Massachusetts General Hospital Cancer Center

Nathan Ledeboer, PhD, Professor and Vice Chair, Pathology and Medical Director, Medical College of Wisconsin

Duncan MacCannell, PhD, CSO, Office of Advanced Molecular Detection, Centers for Disease Control and Prevention

Leidong Mao, PhD, Professor, School of Electrical and Computer Engineering, University of Georgia

Narasimha Marella, PhD, Director, Biomarker Operations, Loxo Oncology, Inc.

Ron Mazumder, PhD, MBA, Vice President, Oncology Biomarker Development & Companion Diagnostics, Genentech

Shawn Mulvaney, PhD, Section Head, Surface Nanoscience and Sensor Technology Section, Chemistry, US Naval Research Laboratory

Matthew Porteus, MD, Professor, Pediatrics, Stanford School of Medicine

Rajagopal Ramesh, PhD, Professor, Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics, Oklahoma TSET Cancer Research Scholar, Department of Pathology; Director, Experimental Therapeutics and Translational Cancer Medicine; Chair, Fellowship Training and Mentoring Program; Member, Stephenson Cancer Center, Stanton L. Young Biomedical Research Center

Andrew Rhim, PhD, Associate Director for Translational Research Ahmed Center for Pancreatic Cancer Research Assistant Professor of Internal Medicine UT MD Anderson Cancer Center

Massimo Saini, PhD, Postdoctoral Researcher, Department of Biomedicine, University of Basel, Switzerland

Julie Shaw, PhD, FCACB, Head, Division of Biochemistry and Director for POCT, Department of Pathology and Laboratory Medicine, The Ottawa Hospital and EORLA

Steven A. Soper, PhD, Professor, Micro and Nanofabricated Tools for Biological Discovery and Medical Diagnostics, University of Kansas

Markus Sprenger-Haussels, PhD, Senior Director, Head of Sample Technologies Product Development Life Sciences, QIAGEN GmbH

Shannon L. Stott, PhD, Assistant Professor, Department of Medicine, Massachusetts General Hospital, Harvard Medical School; BioMEMS Resource Center, The MGH Cancer Center

Ryan J. Sullivan, MD, Associate Director, Melanoma Program, MGH Cancer Center

Ephraim L. Tsalik, MD, MHS, PhD, Associate Professor, Medicine, Duke University School of Medicine; Founder, Predigen, Inc.

Ping Wang, PhD, DABCC, Chief, Clinical Chemistry, Director, Core Laboratory Hospital of University of Pennsylvania

Ross Wilson, PhD, Project Scientist and Principal Investigator, UC Berkeley & the Innovative Genomics Institute

David T.W. Wong, DMD, DMSc, Associate Dean of Research and Felix & Mildred Yip Endowed Distinguished Professor, UCLA School of Dentistry

Adrian Woolfson, BM, BCh, PhD, Executive Vice President, R&D, Sangamo Therapeutics

Paul Yager, PhD, Professor, Bioengineering, University of Washington

Elsie Yu, PhD, DABCC, FACB, System Director, Chemistry, Toxicology and Point-of-Care Testing, Geisinger Medical Laboratories Radiation Oncology and Medical Biophysics, University of Toronto

Digital Health

Christopher M. Hartshorn, PhD, Director, Cancer Treatment and Diagnosis, NCI

Michael Latauska, Director, Digital Health, Boehringer Ingelheim

Raj Pallapothu, mHealth Global Lead, Bayer

Joel Sangerman, Chief Commercial Officer, Click Therapeutics, Inc.

Michael Snyder, PhD, Professor, Genomics & Personalized Medicine, Stanford University

Bio-IT World Conference & Expo WEST

Ben Busby, PhD, Computational Biology Branch, NCBI, NLM, NIH

Atul Butte, MD, PhD, Priscilla Chan and Mark Zuckerberg Distinguished Professor, Director, Bakar Computational Health Sciences Institute, University of California, San Francisco, Chief Data Scientist, University of California Health (UC Health)

Chris Dwan, Senior Technologist and Independent Life Sciences Consultant

Sandor Szalma, PhD, Global Head, Computational Biology, Takeda Pharmaceuticals

Choose your language
Traditional Chinese
Simplified Chinese

Update History
Agenda,Speaker,Sponsor updated

Premier Sponsors